Acomplia is an obesity control medication. It belongs to a new generation of overweight control pills called Cannabinoid-1 Receptor Blockers (CB1). It works by blocking certain receptors which participate in glucose and lipid metabolism. Acomplia decrease the appetite by blocking brain circuits that make you hungry. The main target of the drug is endocannabinoid system. This system is considered to be psychologically important part of body weight regulation.

This medication is used as a part of the whole program created for people who suffer from overweight and have Type 2 diabetes or high cholesterol or sugar levels in the blood. It is also claimed that Acomplia reduces the risk of cardiovascular disease and may help smokers to kick the habit. The drug is predestinated for people with large waist circumference. Acomplia is not approved in the USA. It got official approval of European Union authorities in 2006. It is believed that Acomplia changes moods. In some cases that may be the reason for certain unwanted side effects, for example the increase of suicidal risk in certain type of patients. Do not take Acomplia bought in the USA. That may be dangerous for your health.